The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease

The Reflux questionnaire

Susan Macran, Samantha Wileman, Garry Barton, Ian Russell, REFLUX Trial Group

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Introduction This paper reports on the development of a new measure of health-related quality of life for use among patients with gastro-oesophageal reflux disease (GORD), funded as part of the REFLUX trial. This is a large UK multi centre trial that aims to compare the clinical and cost effectiveness of minimal access surgery with best medical treatment for patients with GORD within the NHS. Method Potential items were identified via a series of interviews and focus groups carried out with patients who were receiving/had received medical or surgical treatment for GORD. The final measure consisted of 31 items covering 7 categories (Heartburn; Acid reflux; Wind; Eating and swallowing; Bowel movements; Sleep; Work, physical and social activities). The measure produced two outputs: a quality of life score (RQLS) and five Reflux symptom scores. Reliability (internal consistency), criterion validity with the SF-36 and, sensitivity to change in terms of relationship with reported change in prescribed medication were assessed amongst a sample of 794 patients recruited into the trial. Results The measure was shown to be internally consistent, to show criterion validity with the SF-36 and sensitive to changes in patients use of prescribed medication at baseline and 3 month follow-up. Discussion The Reflux questionnaire is a new self-administered questionnaire for use amongst patients with GORD. Initial findings suggest that the new measure is valid, reliable, acceptable to respondents and simple to administer in both a clinical and research context.

Original languageEnglish
Pages (from-to)331-343
Number of pages13
JournalQuality of Life Research
Volume16
Issue number2
DOIs
Publication statusPublished - Mar 2007

Keywords

  • gastro-oesophageal reflux disease
  • quality of life
  • scale development
  • anterior partial fundoplication
  • rating-scale
  • symptoms
  • population
  • prevalence
  • Request(TM)
  • validation
  • therapy
  • Gerd

Cite this

The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease : The Reflux questionnaire. / Macran, Susan; Wileman, Samantha; Barton, Garry; Russell, Ian; REFLUX Trial Group.

In: Quality of Life Research, Vol. 16, No. 2, 03.2007, p. 331-343.

Research output: Contribution to journalArticle

@article{f40e15f0a66249eb8db3fd7c18fdae8c,
title = "The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: The Reflux questionnaire",
abstract = "Introduction This paper reports on the development of a new measure of health-related quality of life for use among patients with gastro-oesophageal reflux disease (GORD), funded as part of the REFLUX trial. This is a large UK multi centre trial that aims to compare the clinical and cost effectiveness of minimal access surgery with best medical treatment for patients with GORD within the NHS. Method Potential items were identified via a series of interviews and focus groups carried out with patients who were receiving/had received medical or surgical treatment for GORD. The final measure consisted of 31 items covering 7 categories (Heartburn; Acid reflux; Wind; Eating and swallowing; Bowel movements; Sleep; Work, physical and social activities). The measure produced two outputs: a quality of life score (RQLS) and five Reflux symptom scores. Reliability (internal consistency), criterion validity with the SF-36 and, sensitivity to change in terms of relationship with reported change in prescribed medication were assessed amongst a sample of 794 patients recruited into the trial. Results The measure was shown to be internally consistent, to show criterion validity with the SF-36 and sensitive to changes in patients use of prescribed medication at baseline and 3 month follow-up. Discussion The Reflux questionnaire is a new self-administered questionnaire for use amongst patients with GORD. Initial findings suggest that the new measure is valid, reliable, acceptable to respondents and simple to administer in both a clinical and research context.",
keywords = "gastro-oesophageal reflux disease, quality of life, scale development, anterior partial fundoplication, rating-scale, symptoms, population, prevalence, Request(TM), validation, therapy, Gerd",
author = "Susan Macran and Samantha Wileman and Garry Barton and Ian Russell and {REFLUX Trial Group}",
year = "2007",
month = "3",
doi = "10.1007/s11136-006-9005-3",
language = "English",
volume = "16",
pages = "331--343",
journal = "Quality of Life Research",
issn = "0962-9343",
publisher = "Springer",
number = "2",

}

TY - JOUR

T1 - The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease

T2 - The Reflux questionnaire

AU - Macran, Susan

AU - Wileman, Samantha

AU - Barton, Garry

AU - Russell, Ian

AU - REFLUX Trial Group

PY - 2007/3

Y1 - 2007/3

N2 - Introduction This paper reports on the development of a new measure of health-related quality of life for use among patients with gastro-oesophageal reflux disease (GORD), funded as part of the REFLUX trial. This is a large UK multi centre trial that aims to compare the clinical and cost effectiveness of minimal access surgery with best medical treatment for patients with GORD within the NHS. Method Potential items were identified via a series of interviews and focus groups carried out with patients who were receiving/had received medical or surgical treatment for GORD. The final measure consisted of 31 items covering 7 categories (Heartburn; Acid reflux; Wind; Eating and swallowing; Bowel movements; Sleep; Work, physical and social activities). The measure produced two outputs: a quality of life score (RQLS) and five Reflux symptom scores. Reliability (internal consistency), criterion validity with the SF-36 and, sensitivity to change in terms of relationship with reported change in prescribed medication were assessed amongst a sample of 794 patients recruited into the trial. Results The measure was shown to be internally consistent, to show criterion validity with the SF-36 and sensitive to changes in patients use of prescribed medication at baseline and 3 month follow-up. Discussion The Reflux questionnaire is a new self-administered questionnaire for use amongst patients with GORD. Initial findings suggest that the new measure is valid, reliable, acceptable to respondents and simple to administer in both a clinical and research context.

AB - Introduction This paper reports on the development of a new measure of health-related quality of life for use among patients with gastro-oesophageal reflux disease (GORD), funded as part of the REFLUX trial. This is a large UK multi centre trial that aims to compare the clinical and cost effectiveness of minimal access surgery with best medical treatment for patients with GORD within the NHS. Method Potential items were identified via a series of interviews and focus groups carried out with patients who were receiving/had received medical or surgical treatment for GORD. The final measure consisted of 31 items covering 7 categories (Heartburn; Acid reflux; Wind; Eating and swallowing; Bowel movements; Sleep; Work, physical and social activities). The measure produced two outputs: a quality of life score (RQLS) and five Reflux symptom scores. Reliability (internal consistency), criterion validity with the SF-36 and, sensitivity to change in terms of relationship with reported change in prescribed medication were assessed amongst a sample of 794 patients recruited into the trial. Results The measure was shown to be internally consistent, to show criterion validity with the SF-36 and sensitive to changes in patients use of prescribed medication at baseline and 3 month follow-up. Discussion The Reflux questionnaire is a new self-administered questionnaire for use amongst patients with GORD. Initial findings suggest that the new measure is valid, reliable, acceptable to respondents and simple to administer in both a clinical and research context.

KW - gastro-oesophageal reflux disease

KW - quality of life

KW - scale development

KW - anterior partial fundoplication

KW - rating-scale

KW - symptoms

KW - population

KW - prevalence

KW - Request(TM)

KW - validation

KW - therapy

KW - Gerd

U2 - 10.1007/s11136-006-9005-3

DO - 10.1007/s11136-006-9005-3

M3 - Article

VL - 16

SP - 331

EP - 343

JO - Quality of Life Research

JF - Quality of Life Research

SN - 0962-9343

IS - 2

ER -